Last update 08 May 2025

4-peptide melanoma vaccine(Eisai Co., Ltd.)

Overview

Basic Info

Drug Type
Synthetic peptide vaccine, Therapeutic vaccine
Synonyms-
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
NeoplasmsSkin and Musculoskeletal Diseases
Active Indication-
Inactive Indication
Metastatic melanoma
Originator Organization
Eisai Co., Ltd.Eisai Co., Ltd.
Active Organization-
Inactive Organization
Eisai, Inc.Eisai, Inc.
License Organization-
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with 4-peptide melanoma vaccine(Eisai Co., Ltd.)
NCT00515528
/ TerminatedPhase 2IIT
Randomized Phase II Study of Multipeptide Vaccination With or Without Regulatory T Cell Depletion Using Ontak in Patients With Metastatic Melanoma
100 Clinical Results associated with 4-peptide melanoma vaccine(Eisai Co., Ltd.)
Login to view more data
100 Translational Medicine associated with 4-peptide melanoma vaccine(Eisai Co., Ltd.)
Login to view more data
100 Patents (Medical) associated with 4-peptide melanoma vaccine(Eisai Co., Ltd.)
Login to view more data
100 Deals associated with 4-peptide melanoma vaccine(Eisai Co., Ltd.)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metastatic melanomaPhase 2
United States
Eisai, Inc.Eisai, Inc.
23 Apr 2007
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT00515528 (CTgov)
Phase 2
Metastatic melanoma
17
(Vaccine Alone)
tagqaltrtb(fyxbyakofs) = fnjqshtnmd incznxaxpd (oetowagjia, ljjfjefexj - qhdxhoeiab)
View more
-
29 Oct 2020
(Vaccine Plus Ontak)
tagqaltrtb(fyxbyakofs) = mvfxkxbwhn incznxaxpd (oetowagjia, vhkhcnbqkr - cikjinkcer)
View more
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free